» Articles » PMID: 35159304

Pregnant Women and Endocrine Disruptors: Role of P2X7 Receptor and Mitochondrial Alterations in Placental Cell Disorders

Overview
Journal Cells
Publisher MDPI
Date 2022 Feb 15
PMID 35159304
Authors
Affiliations
Soon will be listed here.
Abstract

In pregnant women, the lungs, skin and placenta are exposed daily to endocrine-disrupting chemicals (EDCs). EDCs induce multiple adverse effects, not only on endocrine organs, but also on non-endocrine organs, with the P2X7 cell death receptor being potentially the common key element. Our objective was first to investigate mechanisms of EDCs toxicity in both endocrine and non-endocrine cells through P2X7 receptor activation, and second, to compare the level of activation in lung, skin and placental cells. In addition, apoptosis in placental cells was studied because the placenta is the most exposed organ to EDCs and has essential endocrine functions. A total of nine EDCs were evaluated on three human cell models. We observed that the P2X7 receptor was not activated by EDCs in lung non-endocrine cells but was activated in skin and placenta cells, with the highest activation in placenta cells. P2X7 receptor activation and apoptosis are pathways shared by all tested EDCs in endocrine placental cells. P2X7 receptor activation along with apoptosis induction could be key elements in understanding endocrine placental and skin disorders induced by EDCs.

Citing Articles

Metabolic Inflammation and Cellular Immunity.

Sindhu S, Ahmad R Cells. 2023; 12(12).

PMID: 37371085 PMC: 10297127. DOI: 10.3390/cells12121615.


Maternal Serum, Cord and Human Milk Levels of Per- and Polyfluoroalkyl Substances (PFAS), Association with Predictors and Effect on Newborn Anthropometry.

Mahfouz M, Harmouche-Karaki M, Matta J, Mahfouz Y, Salameh P, Younes H Toxics. 2023; 11(5).

PMID: 37235269 PMC: 10223184. DOI: 10.3390/toxics11050455.


Endocrine Disruptor Compounds in Environment: Focus on Women's Reproductive Health and Endometriosis.

Interdonato L, Siracusa R, Fusco R, Cuzzocrea S, Di Paola R Int J Mol Sci. 2023; 24(6).

PMID: 36982755 PMC: 10058284. DOI: 10.3390/ijms24065682.


Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells.

Kozlovskiy S, Pislyagin E, Menchinskaya E, Chingizova E, Sabutski Y, Polonik S Toxins (Basel). 2023; 15(1).

PMID: 36668867 PMC: 9864473. DOI: 10.3390/toxins15010047.


Cocktail Effect of Endocrine Disrupting Chemicals: Application to Chlorpyrifos in Lavender Essential Oils.

Fouyet S, Olivier E, Leproux P, Boutefnouchet S, Dutot M, Rat P Int J Environ Res Public Health. 2022; 19(19).

PMID: 36232284 PMC: 9566273. DOI: 10.3390/ijerph191912984.


References
1.
Adinolfi E, Giuliani A, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F . The P2X7 receptor: A main player in inflammation. Biochem Pharmacol. 2017; 151:234-244. DOI: 10.1016/j.bcp.2017.12.021. View

2.
Etzel T, Calafat A, Ye X, Chen A, Lanphear B, Savitz D . Urinary triclosan concentrations during pregnancy and birth outcomes. Environ Res. 2017; 156:505-511. PMC: 5495558. DOI: 10.1016/j.envres.2017.04.015. View

3.
Ferrari D, Los M, Bauer M, Vandenabeele P, Wesselborg S, Schulze-Osthoff K . P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 1999; 447(1):71-5. DOI: 10.1016/s0014-5793(99)00270-7. View

4.
Makrantonaki E, Zouboulis C . Androgens and ageing of the skin. Curr Opin Endocrinol Diabetes Obes. 2009; 16(3):240-5. DOI: 10.1097/MED.0b013e32832b71dc. View

5.
Urabe S, Miyoshi H, Fujiwara H, Yamaoka K, Kudo Y . Enhanced expression of P2X4 and P2X7 purinergic receptors in the myometrium of pregnant rats in preterm delivery models. Reprod Sci. 2009; 16(12):1186-92. DOI: 10.1177/1933719109344630. View